The GMI is at 2. 52-58% of the stocks in the Nasdaq 100, S&P 500 and Dow 30 indexes advanced on Monday. There were 111 new 52 week highs in my universe of 4,000 stocks. The trend of these indexes is just too murky for me right now. I am mainly in cash.
All Posts
GMI: 1; GMI-S: 25; IBD 100 underperform; Down-trend here?
The GMI fell to 1 on Friday, although two of its indicators are too close to be definite. The GMI-S fell to 25, indicating that most of my short term indicators for 4 primary index ETF’s (SPY,DIA,QQQQ,IJR) are negative. There were only 72 new highs in my universe of 4,000 stocks and only 35 successful 10 day new highs (few of the stocks that hit a new high 10 days ago closed higher on Friday than they closed 10 days earlier). The daily indexes for both the SPY and QQQQ are now likely negatives. The DIA daily indicator is also close to turning negative. The IBD Growth Mutual Fund Index is also negative–below its 50 day average. When these fund managers are not doing well, I do not make money buying growth stocks. Only 32% of the Nasdaq 100 stocks rose on Friday, along with 22% of the S&P 500 stocks and 10% of the Dow 30 stocks. Only 52% of the stocks in my universe closed above their 10 week averages, the lowest reading since 52% on August 10, before last summer’s rally.
In addition, according to Monday’s IBD, the put/call ratio on Friday was .41, close to the lowest reading reached in the past 12 months (.38 on March 16, 2006). A low p/c ratio suggests relatively fewer people bearish enough to buy puts, a contrary indicator, often signaling impending market weakness.
The IBD 100 lists of stocks that I have been following also exhibited poor performance, relative to the Nasdaq 100 stocks. Only 19-26% of the stocks in these six lists rose on Friday, compared with 32% of the Nasdaq 100 stocks. And only 25-45% of the stocks closed above their average price of the past 30 days, compared with 49% of the Nasdaq 100 stocks. Some of the lists did have more new highs, though. It is noteworthy that only 35% of the stocks on the IBD 100 list published on 12/18 closed higher than they did on that date. Buying IBD 100 type growth stocks has not been profitable in the past few weeks.
So, with the GMI at 1 and the QQQQ and SPY showing weakness, I bought two of the inverse index ETF’s, QID and SDS. I know I took a loss last week on my prior QID purchases, but this market appears to be in transition with considerable whipsawing going on. Bernard Baruch wrote that he often times bought and sold stocks near the top in 1929, as he tried to catch the major trend. Time will tell if we are at the beginning of a major down-trend. Right now, the prudent course for me is to make small bets on the down-trend with close protective sell stops, in case the market moves up. If the down-trend deepens, I will accumulate the inverse ETF on the weaker index. Be careful out there. This is no longer an upward trending market.
Be sure to read my disclaimers at the bottom of my previous post.
GMI: 5?; 100% cash
The GMI is 5 with a "?" The GMI-S rose to 44, with improvement in the QQQQ short term indicators. It is too early to tell if the Daily QQQQ Index has turned positive. The short term QQQQ trend is just too difficult to decipher. There were only 126 new 52 week highs in my universe of 4,000 stocks. However, 80% of the Nasdaq 100 stocks rose, but only 48-50% of the S&P 500 and Dow 30 stocks. Clearly this was a schizoid market. Only 56% of the IBD 100 stock list from 12/18 advanced. So the gain on Thursday was mainly in the large tech stocks in the Nasdaq 100 index. The leaders, RIMM, GOOG and AAPL all looked good, for a change. With the market trend so murky, I sold my QID with a loss and went to 100% cash. This is not the time for me to make large bets on the QQQQ trend.